Haemonetics Corp (HAE)

R&D to Revenue

4.77%

Quarterly · Period ending:

HAE logo

HAE R&D to Revenue

Latest reported4.77%
HAE Quarterly R&D/Revenue (0.00% → 4.77%)
High-resolution chart · PNG

HAE r&d to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Haemonetics Corp R&D to Revenue — Quarterly
Period endingR&D to Revenue
6.2862%
7.0774%
6.8565%
5.9544%
5.9317%
5.3377%
5.3672%
5.5718%
5.2098%
5.5108%
5.7353%
4.8673%
5.2778%
7.4364%
5.6728%
6.1358%
6.0753%
5.6423%
6.0052%
6.3172%
6.6225%
6.8182%
7.01%
6.5123%
6.25%
6.0117%
6.25%
6.4319%
6.793%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.